Cassava Sciences GAAP EPS of -$0.92

1 hour ago 1

Cassava Sciences press release (NASDAQ:SAVA): Q2 GAAP EPS of -$0.92.
Cash and cash equivalents were $112.4 million, with no debt, as of June 30, 2025. This compares to cash and cash equivalents of $128.6 million as of December 31, 2024.

Recommended For You